Cytodyn Inc COVID-19 Coronavirus Treatment Clinical Data Update Transcript
Good afternoon, everybody, and welcome to Wall Street Reporter's next Super Stock live stream for today, April 17, 2020. We're very proud to bring you a very special presentation from CytoDyn titled on as many of you have been following since August, the stock has done tremendously, the company has reported incredible progress.
And obviously, there's a very topical a presentation for today. As you know, the stock is up significantly and with CytoDyn's impressive pipeline, this could be just the beginning. So today, we have a lot of people on the call. So I'm going to skip my usual remarks. We'll get right to it.
The format for today is simple. Nader Pourhassan, the CEO of CytoDyn is going to speak, then we're going to engage in a panel discussion with Dr. Bruce and Jay, and then we'll open up for Q&A. Hopefully, we'll have time to answer the questions.
We've got about 70 questions. I don't know if we'll have time, but with that being said everybody up, please welcome Dr. Pourhassan. Nader, take it away.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
